My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Gilead Sciences (NQ:GILD)

127.53 +0.35 (+0.28%)

Streaming Delayed Price Updated: 3:51 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

68 69 Next >

2 High-Yield Dividend Stocks to Buy on the Dip ↗

August 08, 2023

The market may have been a bit too harsh on these stocks.

Via The Motley Fool

Gilead Stock Jumps On Strong Q2 Performance Despite Lower Profit Outlook Amid Litigation ↗

August 04, 2023

Gilead Sciences Inc's (NASDAQ: GILD) Q2 FY23 sales increased 6% Y/Y to $6.60 billion, above the consensus of $6.43 billion, primarily driven by increased sales in HIV and Oncology, partially offset by...

Via Benzinga

Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review ↗

August 04, 2023

Amazon, ELF and CAT were earnings winners, but there were big losers too.

Via Investor's Business Daily

Gilead Sciences (GILD) Q2 2023 Earnings Call Transcript ↗

August 04, 2023

GILD earnings call for the period ending June 30, 2023.

Via The Motley Fool

Will An Earnings Miss Cloud Gilead's Massive Cancer Treatment Growth? ↗

August 03, 2023

Gilead missed earnings expectations Thursday, though reported strong sales growth for cancer drugs.

Via Investor's Business Daily

$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today ↗

July 31, 2023

Via Benzinga

Gilead Sciences Announces Second Quarter 2023 Financial Results

August 03, 2023

From Gilead Sciences, Inc.

Via Business Wire

US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month ↗

August 03, 2023

Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost.

Via Benzinga

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points ↗

August 01, 2023

Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

Via InvestorPlace

Expert Ratings for Gilead Sciences ↗

July 24, 2023

Via Benzinga

Peering Into Gilead Sciences's Recent Short Interest ↗

July 19, 2023

Via Benzinga

Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today ↗

July 18, 2023

Via Benzinga

3 Stocks Retirees Should Absolutely Love ↗

July 29, 2023

These stocks offer solid income plus more.

Via The Motley Fool

7 Best Cancer Stocks to Invest in Now

July 28, 2023

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

Via MarketBeat

Topics Death

European Commission Approves Gilead’s Trodelvy® For Pre-Treated HR+/HER2- Metastatic Breast Cancer

July 27, 2023

From Gilead Sciences, Inc.

Via Business Wire

Twice-Yearly Lenacapavir Demonstrates Sustained Impact on Health-Related Quality of Life in People With HIV

July 24, 2023

From Gilead Sciences, Inc.

Via Business Wire

Trial Setback For Gilead Sciences: Shuts Late-Stage Magrolimab/Azacitidine Combo Study In Type Of Blood Cancer ↗

July 24, 2023

Gilead Sciences Inc (NASDAQ: GILD) decided to discontinue the Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes (MDS) due to futility

Via Benzinga

Bank of America, Bank of New York Mellon And 2 Other Stocks Insiders Are Selling ↗

July 24, 2023

The Nasdaq 100 closed slightly higher on Friday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

New Biktarvy® Data Presented at IAS 2023 Further Demonstrate Safety and Efficacy Profile in a Broad Range of People and Communities Affected by the Global HIV Epidemic

July 23, 2023

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences Announces Its Largest Commitment to Health Equity for Australian and Canadian Indigenous Communities

July 23, 2023

From Gilead Sciences, Inc.

Via Business Wire

Governor DeSantis Says He Would Sue the Drug Company Gilead for Trying to Save Lives ↗

July 23, 2023

DeSantis made it clear that he thinks companies should only maximize profit and be subject to shareholder lawsuits if they do anything other than maximizing profits. So how does this get us to suing...

Via Talk Markets

Gilead To Discontinue Phase 3 ENHANCE Study of Magrolimab Plus Azacitidine in Higher-Risk MDS

July 21, 2023

From Gilead Sciences, Inc.

Via Business Wire

Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant From Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

July 20, 2023

From The Center for Disease Analysis Foundation

Via Business Wire

Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.

July 20, 2023

From Gilead Sciences, Inc.

Via Business Wire

Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

July 20, 2023

From CDA Foundation

Via GlobeNewswire

2 Growth Stocks That Could Rocket 81% to 233% Higher, According to Wall Street ↗

July 20, 2023

The investment bank analysts who follow these stocks think they could deliver enormous gains in the not-so-distant future.

Via The Motley Fool

The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023 ↗

July 19, 2023

The market is soaring, but there is still time to buy these seven undervalued Nasdaq stocks before they head higher.

Via InvestorPlace

SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?

July 19, 2023

By David Willey, Benzinga

Via TheNewswire.com

Topics Death

Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023

July 19, 2023

From Gilead Sciences, Inc.

Via Business Wire

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

July 19, 2023

It helps to offer products everyone needs.

Via The Motley Fool

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.